Atlas Trials

NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd

Clinical trial NCT07132749 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07132749
Sponsor
Yeon Hee Park
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Patients With HER2-positive Advanced Breast Cancer Treated With T-DXdPatients With HER2-low Advanced Breast Cancer Treated With T-DXd
Start date
2025-08-12
Primary completion
2026-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.